Clinical Trials Logo

Clinical Trial Summary

This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes, including but not limited to, PMS, peer-reviewed publications, education materials, future regulatory submissions, and/or product development.


Clinical Trial Description

This is an International, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF) study. Data will be collected for the commercially available Perform® Fracture shoulder system in both the anatomic and reversed configurations. The primary endpoint of this study is to demonstrate decreased pain and improved subjects' shoulder functionality of daily living by achieving a mean of American Shoulder and Elbow Surgeons (ASES) shoulder score higher than 62 points, at 2-year follow-up post-operatively, regardless of configuration (anatomic or reverse). Retrospective inclusions are allowed: preoperative and intra operative data can be collected retrospectively up to 2 months after the surgery date. Secondary outcome measures include patient reported outcome measures (PROMs) and standard radiographic findings, including, but not limited to: bone erosion, device migration/subsidence, component breakage, radiolucency, and ossification. Safety and performance data will be collected at surgery, immediate post-op, and up to 10 years post-operation. Patient Reported Outcome Measures (PROMs), device revision and Adverse Events (AEs) will be assessed annually throughout the study. Range of Motion (ROM), strength and radiographic imaging assessments of the study shoulder will also be performed for in-person milestones visits at 6 months (radiographic imaging assessments), 1-, 2-, 5- and 10-year, post-operatively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05773352
Study type Observational
Source Stryker Trauma GmbH
Contact Monica Fleeman
Phone 251-465-5969
Email monica.fleeman@stryker.com
Status Recruiting
Phase
Start date August 31, 2023
Completion date September 1, 2033

See also
  Status Clinical Trial Phase
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A
Terminated NCT03247023 - Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement
Completed NCT03272373 - NexGen TM Tibia Clinical Outcomes Study N/A
Active, not recruiting NCT05049993 - Pyrocarbon Clinical Follow-up Study
Active, not recruiting NCT03664791 - Vanguard Rocc Post Market Surveillance
Completed NCT01859130 - Zimmer POLAR - Total Knee Arthroplasty (TKA) N/A
Terminated NCT02175576 - Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System N/A
Active, not recruiting NCT02199600 - The Medacta International GMK Sphere Post-Marketing Surveillance Study N/A
Completed NCT01010269 - Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study N/A
Withdrawn NCT00589485 - Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement N/A
Active, not recruiting NCT02337244 - Zimmer POLAR Persona - TKA (EMEA Study)
Terminated NCT00579059 - Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia N/A
Withdrawn NCT01462240 - LPS Flex Porous Femoral Components
Recruiting NCT03048201 - Physica System Total Knee Replacement Registry Study N/A
Completed NCT02087436 - Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density N/A
Recruiting NCT01542580 - A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
Active, not recruiting NCT00698854 - A Clinical Investigation of the Vanguard™ Complete Knee System
Recruiting NCT05787821 - Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Not yet recruiting NCT04918680 - Prospective Post-market Study Examining the Effectiveness of the EcoFit®
Withdrawn NCT05037734 - A Randomized Controlled Trial for Partial Knee Arthroplasty N/A